Abbvie as competition Abbvie's CEO hasn't turned the juice on Allergan (a company ABBV bought last year) and he's very competitive. When he turns it on, it will hurt EVNC. Be careful with RVNC. He wishes he liked Revance more. He knows this group (aesthetics) and Abbvie produces the popular Botox.
Revance Therapeutics is a American stock, trading under the symbol RVNC-Q on the NASDAQ (RVNC). It is usually referred to as NASDAQ:RVNC or RVNC-Q
In the last year, there was no coverage of Revance Therapeutics published on Stockchase.
Revance Therapeutics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Revance Therapeutics.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Revance Therapeutics published on Stockchase.
On 2024-10-04, Revance Therapeutics (RVNC-Q) stock closed at a price of $5.22.
There's demand for products to improve skin care and appearance, because people want to look good.